Delayed-type hypersensitivity reaction with iscador M given in combination with cytotoxic chemotherapy.
Shaw
Heather S
HS
Hobbs
Katherine B
KB
Kroll
David J
DJ
Seewaldt
Victoria L
VL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000209:etiology*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D010936:Plant Extracts / Q000008:administration & dosage / Q000009:adverse effects*; D010940:Plant Proteins / Q000008:administration & dosage / Q000009:adverse effects*; D000093542:Gemcitabine
D010936:Plant Extracts; D010940:Plant Proteins; D003841:Deoxycytidine; C077177:viscum album peptide; D005472:Fluorouracil; D008727:Methotrexate; D000093542:Gemcitabine